A new trading day began on Tuesday, with GoodRx Holdings Inc (NASDAQ: GDRX) stock price up 2.62% from the previous day of trading, before settling in for the closing price of $7.62. GDRX’s price has ranged from $4.14 to $9.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 26.70% over the past five years. Meanwhile, its annual earnings per share averaged 29.74%. With a float of $77.35 million, this company’s outstanding shares have now reached $92.36 million.
Let’s look at the performance matrix of the company that is accounted for 694 employees.
GoodRx Holdings Inc (GDRX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of GoodRx Holdings Inc is 79.38%, while institutional ownership is 14.91%. The most recent insider transaction that took place on Nov 30 ’23, was worth 124,806. In this transaction an insider of this company bought 21,652 shares at a rate of $5.76, taking the stock ownership to the 182,900 shares. Before that another transaction happened on Nov 29 ’23, when Company’s See Remarks bought 26,348 for $5.90, making the entire transaction worth $155,482. This insider now owns 161,248 shares in total.
GoodRx Holdings Inc (GDRX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 29.74% per share during the next fiscal year.
GoodRx Holdings Inc (NASDAQ: GDRX) Trading Performance Indicators
Here are GoodRx Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.84. Likewise, its price to free cash flow for the trailing twelve months is 19.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.02, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 0.45 in one year’s time.
Technical Analysis of GoodRx Holdings Inc (GDRX)
GoodRx Holdings Inc (NASDAQ: GDRX) saw its 5-day average volume 1.13 million, a negative change from its year-to-date volume of 1.49 million. As of the previous 9 days, the stock’s Stochastic %D was 9.72%. Additionally, its Average True Range was 0.34.
During the past 100 days, GoodRx Holdings Inc’s (GDRX) raw stochastic average was set at 60.58%, which indicates a significant increase from 21.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.49% in the past 14 days, which was lower than the 58.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.49, while its 200-day Moving Average is $6.47. Nevertheless, the first resistance level for the watch stands at $7.95 in the near term. At $8.07, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.31. If the price goes on to break the first support level at $7.59, it is likely to go to the next support level at $7.35. The third support level lies at $7.23 if the price breaches the second support level.
GoodRx Holdings Inc (NASDAQ: GDRX) Key Stats
With a market capitalization of 2.93 billion, the company has a total of 375,205K Shares Outstanding. Currently, annual sales are 750,270 K while annual income is -8,870 K. The company’s previous quarter sales were 197,880 K while its latest quarter income was -1,010 K.
